The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

EU Logoefpia Logo


STAKEHOLDER FORUM 2015 - Registration now open

This year's IMI Stakeholder Forum will take place on Monday 15 June in Brussels, Belgium.

Join us to learn about IMI's achievements so far and give input on our future activities and plans!



  • A life-saving technology

    IMI project SUMMIT has developed an ultrasound device to identify patients at imminent risk of a heart attack or stroke

    ... more
  • Action on autism

    Watch a video on how EU-AIMS is developing tools to boost our understanding of autism, paving the way for new treatments

    ... more
  • COMBACTE open call

    Antimicrobial resistance project COMBACTE has launched an open call for new clinical trial programmes/studies - deadline 29 April

    ... more
  • Dealing with medicines benefits & risks

    The PROTECT project has developed tools and materials to help weigh up the benefits and risks of medicines

    ... more
  • Get on-course!

    With over 6 000 courses, on-course, run by the EMTRAIN project, is Europe's most comprehensive biomedical R&D postgrad course portal

    ... more
  • GetReal wants your views

    The GetReal project wants your views on the use of real world data in drug development & clinical effectiveness assessment.

    ... more
  • Innovation in action

    IMI's projects tackle some of the toughest challenges in medicine, including Alzheimer's disease, diabetes, & antibiotic development ... more

  • Patient power!

    EUPATI is developing educational resources that will empower patients to engage more effectively in the drug research and development process

    ... more
  • Towards better clinical trials

    The NEWMEDS project has developed DupCheck, a tool to spot duplicate enrolments in clinical trials

    ... more
  • Working in drug discovery?

    The European Lead Factory’s compound collection & screening facilities could help advance your research

    ... more
All projects


The IMI 2 - Call 5 draft text is now online.

Topics cover:

  • Patient perspective on benefits/risks of medicines
  • Diabetic kidney disease
  • Alzheimer's disease / cognitive impairment



  • 22/05/2015 : RT @IMI_LifeTrain: New @IMI_LifeTrain case study online: @OrionPharma's CrossTraining - learning from colleagues, ht…
  • 22/05/2015 : RT @AD_PREVENT: What a week #bbc interview, @IMI_EPAD assembly with @IMI_JU @JanssenEMEA @AlzheimerEurope all playing huge part. #DAW2015 m…
  • 21/05/2015 : US @HouseCommerce committee votes unanimously in favour of #Cures2015, which mentions IMI @ECcures

Follow us on Twitter